Fentanyl dabbing with cannabis retail equipment: an ethnographic and drug-checking study
In the authors' words
Background: Fentanyl's entrenchment in U.S. West Coast drug markets brought a shift from injecting to smoking illicit opioids. We characterize the next transition: the rise of 'dabbing,' vaporizing fentanyl with equipment sold for cannabis concentrates. Methods: This mixed-methods study combined ethnographic interviewing and participant observation among people who use fentanyl in California and Oregon (2024-2026) with survey data from a Los Angeles drug checking program. After identifying dabbing ethnographically, we added an optional smoking-method item to the survey. Results: Of 108 participants who stated a route of administration, 104 (96%) reported smoking; of 93 who named a smoking method, 81 (87%) reported dabbing. All 11 who first named another method and returned later then reported dabbing. Dabbing was reported at 250 of 405 (62%) encounters with a stated route. We observed participants adapting cannabis equipment. They praised dabbing's discretion, reduced stigma, and convenience, and its capacity for more large hits, more quickly; the same speed led some to call it wasteful, because it went through their fentanyl faster than other methods. Participants described rapidly rising tolerance and frequent dabbing-related burns, which we also observed. Some who had injected said dabbing approximated its "rush." Conclusions: Dabbing has become the dominant way to consume fentanyl among people using drug checking services in Los Angeles, and was observed in every other city where we did fieldwork. Clinicians and programs should ask people how they smoke fentanyl, not only whether they smoke or inject; dabbing may reduce some risks while increasing others.
In plain words AI summary
Researchers studied how people use fentanyl by interviewing and observing users in California and Oregon. However, they also reported rising tolerance, frequent burns, and using up their fentanyl faster. The authors suggest clinicians should ask specifically about dabbing, as it may reduce some risks while increasing others.
Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source. 2 sentences were removed for not being supported by the abstract.
Appeared: Tuesday, November 17. medRxiv. Preprint, not yet peer-reviewed.